Clinical Trials Logo

Clinical Trial Summary

The rationale of MIDA trial is to determine efficacy and tolerability of ranolazine molecule among Pakistan population and obtain firsthand knowledge about the molecule ranolazine.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03486561
Study type Interventional
Source OBS Pakistan
Contact Faizan Shaukat
Phone +923328814816
Email faizan.shaukat@obs.com.pk
Status Not yet recruiting
Phase Phase 4
Start date April 1, 2018
Completion date October 31, 2018

See also
  Status Clinical Trial Phase
Recruiting NCT02908776 - MYocardial DAmage AND MIcrobiota STUDY N/A
Recruiting NCT01397994 - Study to Assess Efficacy of Nicorandil+Atenolol vs Atenolol in Treatment of Chronic Stable Angina. Phase 4
Active, not recruiting NCT00350922 - A Clinical Trial of a Self-Management Education Program for People With Chronic Stable Angina Phase 1
Completed NCT02078921 - The Effects of Inorganic Nitrate on Cardiac Muscle in Angina Phase 2
Recruiting NCT02591758 - Novel Vitality Indices Derived From the Hexoskin in Patients Affected With Angina Undergoing Coronary Revascularization or Medical Therapy N/A
Terminated NCT03346278 - Text Message Intervention to Improve Cardiac Rehab Participation N/A
Enrolling by invitation NCT03063697 - Observational Study to Evaluate the Safety of DILATREND SR Cap. in Korean Patients With Essential Hypertension, Chronic Stable Angina and Congestive Heart Failure N/A
Completed NCT01239511 - Phase IIb Study of STA-2 in Patients With Chronic Stable Angina Phase 2
Active, not recruiting NCT02722213 - Mindfulness & Stress Management Study for Cardiac Patients N/A
Completed NCT01484912 - Phase II Study of STA-2 in Patients With Chronic Stable Angina Phase 2
Recruiting NCT02710435 - REDUCER-I: An Observational Study of the Neovasc Reducerâ„¢ System N/A
Withdrawn NCT00518921 - Capadenoson in Angina Pectoris Phase 2
Withdrawn NCT02423265 - Efficacy of Ranolazine in Patients With Chronic Total Occlusions of Coronary Arteries Phase 4
Completed NCT01369472 - Evaluating Dose-proportionality of Dilatrend Suspended-Release Capsule Phase 1
Completed NCT01340248 - A Randomized, Open-label, Single-dose, Crossover Clinical Trial to Evaluate the Food Effect on the Pharmacokinetics of Dilatrend SR 64mg Capsule After Oral Administration in Healthy Male Volunteers Phase 1
Completed NCT02315001 - Liraglutide to Improve corONary Haemodynamics During Exercise streSS Phase 2
Active, not recruiting NCT01760083 - A Randomized Multicentre Trial to Evaluate the Utilization of Revascularization or Optimal Medical Therapy for the Treatment of Chronic Total Coronary Occlusions N/A
Unknown status NCT01558830 - Safety of Amiodarone and Ranolazine Together in Patients With Angina Phase 4
Active, not recruiting NCT01864031 - The Role of Alcohol Consumption in the Aetiology of Different Cardiovascular Disease Phenotypes: a CALIBER Study N/A
Completed NCT01804439 - Risk Factors in the Initial Presentation of Specific Cardiovascular Disease Syndromes N/A